{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:37:45Z","timestamp":1780943865392,"version":"3.54.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HMER"],"DOI":"10.2147\/hmer.s91709","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T03:55:13Z","timestamp":1472788513000},"page":"89-95","source":"Crossref","is-referenced-by-count":37,"title":["Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection"],"prefix":"10.2147","volume":"Volume 8","author":[{"given":"Christopher","family":"Bowlus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,9]]},"container-title":["Hepatic Medicine: Evidence and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=32202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T23:04:02Z","timestamp":1477868642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/obeticholic-acid-for-the-treatment-of-primary-biliary-cholangitis-in-a-peer-reviewed-article-HMER"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/hmer.s91709","relation":{},"ISSN":["1179-1535"],"issn-type":[{"value":"1179-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}